Centocor
Executive Summary
Former SmithKline VP James Geddes joins monoclonal antibody firm as VP-sales & marketing, therapeutic products. His initial activities at Centocor will focus on prelaunch and launch activities for Centoxin, a product for treatment of septic shock. He is also charged with establishing a U.S.-based therapeutic sales force. Geddes joined SmithKline in 1968 and most recently directed the company's government, customer relations and national accounts programs as a VP in the U.S. Pharmaceuticals Marketing Division of Smith Kline & French.